Beta-blockers… What is an attitude to it?
The issues of use of beta-blockers as first-line antihypertensive treatment and their negative metabolic effects are debated during last two years. At the same time beta-blockers are heterogeneous class of drugs, characteristics some of them may be different. At the article was presented the results of examination of 50 patients with hypertension 1-2 stage and high risk of cardiovascular complication which have confirmed the previous data that betaxolol is metabolic neutral, effective and good carried beta-blocker